- £254.91m
- £294.18m
- £0.55m
- 22
- 19
- 48
- 18
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0 | 0 | 0.549 |
Cost of Revenue | |||
Gross Profit | 0 | -0.015 | 0.488 |
Selling / General / Administrative Expenses | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 0 | 1.97 | 4.23 |
Operating Profit | 0 | -1.97 | -3.69 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 0 | -12 | -34.1 |
Provision for Income Taxes | |||
Net Income After Taxes | 0 | -12 | -34.1 |
Net Income Before Extraordinary Items | |||
Net Income | 0 | -12 | -34.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 0 | -12 | -34.1 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0 | -0.066 | -0.175 |
Dividends per Share |